Results 41 to 50 of about 1,839,175 (269)

Predictive signs of dysgraphia: graphesthesia as a soft sensory finding in children with writing difficulties in Arabic language

open access: yesThe Egyptian Journal of Otolaryngology, 2023
Background Dysgraphia is one of the learning disabilities that require a complex set motor actions. It affects writing skills in the form of poor handwriting, spelling problems, and difficulty in writing thoughts and ideas.
Rania Makram Sidhom, Ghada Tarek Orabi
doaj   +1 more source

The structural brain correlates of neurological soft signs in ÆSOP first-episode psychoses study

open access: yes, 2003
Patients with schizophrenia and related psychoses have an excess of minor neurological abnormalities (neurological soft signs) of unclear neuropathological origin. These include poor motor coordination, sensory perceptual difficulties and difficulties in
Salvo, J.   +13 more
core   +1 more source

Dyslexia: Links with schizotypy and neurological soft signs

open access: yesPsyCh Journal, 2021
AbstractAbnormalities in language processing, psychological distress, and subtle neurodevelopmental features called neurological soft signs (NSS) are expressed by people with dyslexia and those scoring highly on schizotypy. We investigated whether the expression of NSS, distress, and schizotypy predicted dyslexia status.
Emma Barkus   +5 more
openaire   +2 more sources

Phenomenology and clinical relevance of minor neurological signs in child neurology and psychiatry

open access: yesFrontiers in Neurology
Minor Neurological Signs, also referred to as neurological soft signs, are subtle abnormalities detected during neurological examination that do not meet criteria for major focal deficits.
Francesca Magostini   +2 more
doaj   +1 more source

Relationship between P300 findings and neurological soft signs in patients with first episode schizophrenia [PDF]

open access: yesDüşünen Adam Psikiyatri ve Nörolojik Bilimler Dergisi, 2011
Objective: In this study, the relationship between neurological soft signs and P300 components was explored in patients with schizophrenia. Method: 22 first-episode schizophrenia patients who were evaluated according to DSM-IV criteria and whose disease ...
Mehmet Yücel   +4 more
doaj  

Neurological Soft Signs: A Further Step in the Diagnosis of Bipolar-I Disorder? [PDF]

open access: yesIranian Journal of Psychiatry, 2009
Objectives:  To study the prevalence and demographic characteristics of Neurological Soft Signs (NSS) among the patients with Bipolar Mood Disorder-I (BID).
Parastoo Irandoost   +4 more
doaj   +2 more sources

Neurological Soft Signs in Patients with Psychotic Symptoms and without Psychotic Symptoms: A Direct Comparison

open access: yesJournal of Psychiatry Spectrum, 2022
Background: The neurological abnormalities known as neurological soft signs (NSSs), which manifest in some mentally ill individuals, are categorized as “soft” to represent a lack of precise cerebral location.
Ambika Sadashiv Kabade   +1 more
doaj   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

The Effect of Methylphenidate on Neurological Soft Signs in ADHD [PDF]

open access: yesPsychiatry Investigation, 2015
Neurological soft signs are very common in children with the attention deficit hyperactivity disorder (ADHD), and the first line medication of this disorder is methylphenidate. The aim of the study was to assess the effect of methylphenidate on the neurological soft signs in children and adolescents suffering from ADHD depending on the dose of ...
Hrtanek, Igor   +6 more
openaire   +2 more sources

Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy